{"id":24898,"date":"2025-09-24T09:43:44","date_gmt":"2025-09-24T07:43:44","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/intelligenza-artificiale-e-chimica-farmaceutica\/"},"modified":"2025-09-25T15:46:27","modified_gmt":"2025-09-25T13:46:27","slug":"intelligenza-artificiale-e-chimica-farmaceutica","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/","title":{"rendered":"Artificial Intelligence and Pharmaceutical Chemistry"},"content":{"rendered":"<p data-start=\"370\" data-end=\"1030\">The use of artificial intelligence in drug discovery is entering a stage of maturity: no longer just a tool for data management or property prediction, but a truly generative instrument. A recent study published in the <em data-start=\"339\" data-end=\"380\">European Journal of Medicinal Chemistry<\/em> by Lisa Piazza, Sanjana Srinivasan, Tiziano Tuccinardi, and J\u00fcrgen Bajorath demonstrates how <strong>Chemical Language Models (CLMs)<\/strong> can transform molecular fragments into structurally and topologically novel compounds, achieving a level of diversification that challenges conventional methods.<\/p>\n<h2 data-start=\"1032\" data-end=\"1072\">From natural language to chemistry<\/h2>\n<p data-start=\"104\" data-end=\"500\">At the heart of this research lies a simple yet powerful idea: if transformers have revolutionized natural language processing, why not apply them to the &#8220;language of molecules&#8221;? Chemical compounds can be represented as strings (SMILES), that is, sequences of symbols encoding atoms and bonds. Just like the words in a sentence, molecular fragments can also be learned, combined, and transformed.<\/p>\n<p data-start=\"502\" data-end=\"537\">The authors developed three models:<\/p>\n<ul data-start=\"539\" data-end=\"813\">\n<li data-start=\"539\" data-end=\"615\">\n<p data-start=\"541\" data-end=\"615\"><strong data-start=\"541\" data-end=\"552\">C model<\/strong>, trained exclusively on molecular cores (central scaffolds);<\/p>\n<\/li>\n<li data-start=\"616\" data-end=\"668\">\n<p data-start=\"618\" data-end=\"668\"><strong data-start=\"618\" data-end=\"629\">S model<\/strong>, trained on substituents (R-groups);<\/p>\n<\/li>\n<li data-start=\"669\" data-end=\"813\">\n<p data-start=\"671\" data-end=\"813\"><strong data-start=\"671\" data-end=\"683\">CS model<\/strong>, the most ambitious one, capable of integrating a core and two substituents without any prior information about their connection.<\/p>\n<\/li>\n<\/ul>\n<h2 data-start=\"1828\" data-end=\"1872\">Pushing beyond traditional boundaries<\/h2>\n<p data-start=\"80\" data-end=\"393\">In traditional <em data-start=\"95\" data-end=\"104\">de novo<\/em> design approaches, chemical constraints and bonding rules play a fundamental role. Here, however, the models were trained <strong>without any explicit connection rules<\/strong>, learning directly from the associations between molecular fragments and bioactive compounds extracted from the ChEMBL database.<\/p>\n<p data-start=\"395\" data-end=\"835\">The results are remarkable. The CS model achieved an 80% validity rate in generating compounds containing the input fragment combinations, with an unexpectedly high degree of diversification. Even the <strong>simpler models displayed noteworthy behavior<\/strong>: the C model, although less productive, generated more than 70% of scaffolds never encountered in the training data, demonstrating a level of chemical creativity that goes beyond mere imitation.<\/p>\n<h2 data-start=\"2656\" data-end=\"2705\">Novel structures and expanding chemical diversity<\/h2>\n<p data-start=\"91\" data-end=\"368\">One of the most challenging aspects of molecular generation is distinguishing between mere reproduction and genuine innovation. In this study, the researchers demonstrated that <strong>the majority of the generated compounds were novel<\/strong>, with structures not present in the training set.<\/p>\n<p data-start=\"370\" data-end=\"672\" data-is-last-node=\"\" data-is-only-node=\"\">Analysis according to the Bemis\u2013Murcko hierarchy revealed that more than 50% of the scaffolds and 30\u201340% of the carbon skeletons were original. This is therefore not just a case of cosmetic variations, but of <strong>new molecular topologies<\/strong> that concretely expand the chemical space available for exploration.<\/p>\n<h2 data-start=\"3275\" data-end=\"3317\">Biological relevance and the bioactive landscape<\/h2>\n<p data-start=\"84\" data-end=\"517\">An inevitable question is whether this creativity is pharmacologically useful. The data suggest that it is: by comparing the generated compounds with bioactive molecules in ChEMBL, <strong>thousands of structural analogues of active compounds<\/strong> targeting more than 1,300\u20131,600 different proteins were identified. In other words, the models not only invent new molecules, but do so in a direction with a high likelihood of biological relevance.<\/p>\n<p data-start=\"519\" data-end=\"732\" data-is-last-node=\"\" data-is-only-node=\"\">A particularly striking example is that of enzyme inhibitors reproduced almost exactly by the CS model, demonstrating the algorithm\u2019s ability to capture implicit chemical rules that were never explicitly provided.<\/p>\n<h2 data-start=\"3948\" data-end=\"3991\">Accessibilit\u00e0 sintetica e drug-likeness<\/h2>\n<p data-start=\"77\" data-end=\"478\">A critical challenge for generative models concerns the <strong>practical feasibility of the molecules they produce<\/strong>. It would make little sense to propose structures that, while theoretically plausible, cannot be synthesized in the laboratory. To address this, the researchers calculated synthetic accessibility (SA) and drug-likeness (QED) scores, comparing them with real compounds from the ChEMBL database.<\/p>\n<p data-start=\"480\" data-end=\"819\" data-is-last-node=\"\" data-is-only-node=\"\">The result is reassuring: the new candidates exhibited SA and QED values <strong>comparable to those of known drugs<\/strong>, with average scores of 2.44 for synthesis (versus 2.73 for real compounds) and 0.56 for \u201cchemical beauty\u201d (versus 0.53). In other words, the generated compounds are not only novel and diverse, but also <strong>credible as potential drugs<\/strong>.<\/p>\n<h2 data-start=\"4741\" data-end=\"4771\">Strengths and Limitations<\/h2>\n<p data-start=\"84\" data-end=\"129\">The study presents several clear strengths:<\/p>\n<ul data-start=\"131\" data-end=\"525\">\n<li data-start=\"131\" data-end=\"274\">\n<p data-start=\"133\" data-end=\"274\">it demonstrates the possibility of generating new molecules without predefined bonding constraints, relying solely on statistical learning;<\/p>\n<\/li>\n<li data-start=\"275\" data-end=\"410\">\n<p data-start=\"277\" data-end=\"410\">it produces results relevant to fragment-based drug design, expanding the range of options for hit expansion and lead optimization;<\/p>\n<\/li>\n<li data-start=\"411\" data-end=\"525\">\n<p data-start=\"413\" data-end=\"525\">it makes both the code and dataset publicly available, a significant contribution to the scientific community.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"527\" data-end=\"912\" data-is-last-node=\"\" data-is-only-node=\"\">However, some limitations remain. The lower validity of the C model suggests that not all fragment-based approaches are equivalent and that combining multiple structural cues is crucial. Moreover, the actual biological activity of the generated compounds has yet to be demonstrated experimentally: the fact that they are analogues of known molecules is encouraging, but not sufficient.<\/p>\n<h2 data-start=\"5599\" data-end=\"5643\">Implications for Pharmaceutical Research<\/h2>\n<p data-start=\"81\" data-end=\"498\">In a field where the average cost of developing a drug exceeds two billion dollars and timelines are increasingly compressed, tools capable of c<strong>hemically navigating &#8220;empty spaces&#8221;<\/strong> hold enormous strategic potential. The approach proposed by Piazza and colleagues does not replace synthetic chemistry or pharmacological evaluation, but it <strong>dramatically reduces the gap between existing data and new molecular hypotheses<\/strong>.<\/p>\n<p data-start=\"500\" data-end=\"837\" data-is-last-node=\"\" data-is-only-node=\"\">Moreover, the availability of open-source models and public datasets paves the way for a democratization of AI tools for drug discovery, with significant ethical and industrial implications \u2014 from accelerating academic research to enabling small biotech companies to access technologies that were once the exclusive domain of big pharma.<\/p>\n<h2 data-start=\"6423\" data-end=\"6438\">Conclusion<\/h2>\n<p data-start=\"84\" data-end=\"423\">The study represents an important milestone in the convergence between artificial intelligence and pharmaceutical chemistry. If the molecular creativity of language models is confirmed in experimental phases, we could be witnessing a paradigm shift: no longer chemistry dictating rules to AI, but AI suggesting new chemistries to research.<\/p>\n<p data-start=\"425\" data-end=\"794\" data-is-last-node=\"\" data-is-only-node=\"\">As the authors emphasize, the method lends itself not only to the expansion of existing scaffolds but also to fragment-guided lead optimization, with the potential for immediate impact on library design and pharmaceutical innovation. The challenge now is to transform these computer-generated strings into real molecules \u2014 in the laboratory and, one day, in the clinic.<\/p>\n<p data-start=\"6809\" data-end=\"7195\"><strong>Reference:<\/strong> Lisa Piazza, Sanjana Srinivasan, Tiziano Tuccinardi, J\u00fcrgen Bajorath,<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117615\" target=\"_blank\" rel=\"noopener\">Transforming molecular cores, substituents, and combinations into structurally diverse compounds using chemical language models<\/a>, European Journal of Medicinal Chemistry,<br \/>\nVolume 291, 2025, 117615, ISSN 0223-5234.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A study shows that transformer-based chemical language models can transform molecular cores and substituents into novel and diverse compounds. The generated molecules exhibit good synthetic accessibility and potential biological relevance, with significant implications for drug design.<\/p>\n","protected":false},"author":32,"featured_media":24867,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[837,1101],"tags":[],"class_list":{"0":"post-24898","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-artificial-intelligence","8":"category-highlights-en"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Artificial Intelligence and Pharmaceutical Chemistry - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"I modelli linguistici chimici generano nuove molecole a partire da frammenti strutturali aprendo prospettive per la scoperta di farmaci.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artificial Intelligence and Pharmaceutical Chemistry - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"I modelli linguistici chimici generano nuove molecole a partire da frammenti strutturali aprendo prospettive per la scoperta di farmaci.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-24T07:43:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-25T13:46:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\"},\"headline\":\"Artificial Intelligence and Pharmaceutical Chemistry\",\"datePublished\":\"2025-09-24T07:43:44+00:00\",\"dateModified\":\"2025-09-25T13:46:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\"},\"wordCount\":961,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png\",\"articleSection\":[\"Artificial intelligence\",\"HIGHLIGHTS\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\",\"name\":\"Artificial Intelligence and Pharmaceutical Chemistry - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png\",\"datePublished\":\"2025-09-24T07:43:44+00:00\",\"dateModified\":\"2025-09-25T13:46:27+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\"},\"description\":\"I modelli linguistici chimici generano nuove molecole a partire da frammenti strutturali aprendo prospettive per la scoperta di farmaci.\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png\",\"width\":1536,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artificial Intelligence and Pharmaceutical Chemistry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artificial Intelligence and Pharmaceutical Chemistry - MakingPharmaIndustry","description":"I modelli linguistici chimici generano nuove molecole a partire da frammenti strutturali aprendo prospettive per la scoperta di farmaci.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/","og_locale":"en_US","og_type":"article","og_title":"Artificial Intelligence and Pharmaceutical Chemistry - MakingPharmaIndustry","og_description":"I modelli linguistici chimici generano nuove molecole a partire da frammenti strutturali aprendo prospettive per la scoperta di farmaci.","og_url":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-09-24T07:43:44+00:00","article_modified_time":"2025-09-25T13:46:27+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25-1024x683.png","type":"image\/png"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f"},"headline":"Artificial Intelligence and Pharmaceutical Chemistry","datePublished":"2025-09-24T07:43:44+00:00","dateModified":"2025-09-25T13:46:27+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/"},"wordCount":961,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png","articleSection":["Artificial intelligence","HIGHLIGHTS"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/","url":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/","name":"Artificial Intelligence and Pharmaceutical Chemistry - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png","datePublished":"2025-09-24T07:43:44+00:00","dateModified":"2025-09-25T13:46:27+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f"},"description":"I modelli linguistici chimici generano nuove molecole a partire da frammenti strutturali aprendo prospettive per la scoperta di farmaci.","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/ChatGPT-Image-22-set-2025-12_46_25.png","width":1536,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/intelligenza-artificiale-e-chimica-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Artificial Intelligence and Pharmaceutical Chemistry"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=24898"}],"version-history":[{"count":4,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24898\/revisions"}],"predecessor-version":[{"id":24903,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24898\/revisions\/24903"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/24867"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=24898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=24898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=24898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}